CA 15-3 ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM— 510(k) K022178

Name: FDA 510(k) clearance K022178
Creator: U.S. Food and Drug Administration
Published: 2002-11-12

Substantially Equivalent

Bayer Diagnostics Corp.

FDA 510(k) clearance K022178 for CA 15-3 ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM, Substantially Equivalent on 2002-11-12. Applicant: Bayer Diagnostics Corp.. Device class: 2.

Clearance details

Applicant: Bayer Diagnostics Corp.
Product code: Code MOI
Device class: Class 2
Regulation: 21 CFR 866.6010
Advisory panel: Immunology
Date received: 2002-07-03
Decision date: 2002-11-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code MOI

view all

K240403 — Access BR Monitor2024-05-09
K233946 — IMMULITE® 2000 BR-MA2024-03-13
K192524 — Lumipulse G CA15-32020-09-04
K193489 — ADVIA Centaur BR2020-02-13
K192777 — ADVIA Centaur CA 15-3 assay2019-11-22

More clearances from Bayer Diagnostics Corp.

view all

K033379 — BAYER SPECIAL CHEMISTRY CONTROLS2003-12-19
K033380 — BAYER SPECIAL CHEMISTRY CALIBRATORS2003-12-16
K033007 — BAYER ADVIA DIGOXIN ASSAY FOR THE INTEGRATED MODULE SYSTEM2003-11-14
K031857 — ADVIA CHEMISTRY ALPHA-1 ANTITRYPSIN ASSAY2003-09-04
K022096 — URIC ACID ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM2003-03-18

Data sourced from openFDA. This site is unofficial and independent of the FDA.